Sigma Pharmaceutical Limited (ASX: SIP) today announced a return to full-year profit, after a tough few years. It booked a $49 million profit, after a loss of $235 million last year. Excluding discontinued operations, the company improved to a $50 million profit, up from a $73 million loss in the prior year.

We outlined some of the pharmacy wholesaler’s recent problems last week, including overpaying for acquisitions, suffering the loss of Pfizer’s drug distribution business (Pfizer is distributing its products direct to pharmacies, bypassing Sigma and the other wholesalers, including Australian Pharmaceutical Industries Ltd (ASX: API)) and most recently a strike at its Rowville distribution centre.

The company will pay a full-year dividend of 2 cents, and a special dividend of 1.5 cents, both fully-franked, capping a phoenix-like year for the company, with the shares rebounding from a low of $0.28 12 months ago to $0.645 in afternoon trade today.

That jump looks impressive – and it is, if you were lucky enough to buy shares at their lows. The shares are still down from a high of $0.89 they hit 2.5 years ago and an all-time high of $2.16 in 2005, so long term shareholders will appreciate the up-tick, but there’s a long way to go before they are made whole.

Risks still abound – with the company highlighting the upcoming cuts to the Pharmaceutical Benefits Scheme and the chance that another major pharmaceutical supplier may follow Pfizer’s lead and deliver its products directly.

The management team deserve plaudits for righting the ship, but there’s still a long way to go before it’s at cruising speed and under full sail – and a safe distance from the menacing rocks that are still well in sight.

If you are looking for ASX investing ideas, look no further than “The Motley Fool’s Top Stock for 2012.” In this free report, Investment Analyst Dean Morel names his top pick for 2012…and beyond. Click here now to find out the name of this small but growing telecommunications company. But hurry – the report is free for only a limited period of time.

More reading

Scott Phillips is a Motley Fool investment analyst. You can follow him on Twitter @TMFGilla. The Motley Fool’s purpose is to educate, amuse and enrich investors. This article contains general investment advice only (under AFSL 400691)

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.